Boston Globe: Kendall Square is no longer the area’s only biotech hotspot

The following is an excerpt from a front page story in The Boston Globe on January 31, 2024.

Many have gravitated to Kendall Square partly because of its celebrated “bump factor,” the ease with which drug developers and financers can run into each other in the dense neighborhood. But that phenomenon has also created a kind of bubble of highly educated scientists and entrepreneurs seemingly removed from the rest of the state and all it has to offer.

“For a long time, when people thought about life sciences, they thought about Cambridge,” said Kendalle Burlin O’Connell, the MassBio chief executive. “Research and development is Cambridge’s sweet spot. But there are capabilities in the Merrimack Valley and in Worcester. Land is cheaper, and you can tap into a whole new workforce.”

Business leaders and…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks